Red-cell bound anti-A is more efficient than anti-B in competition for fluid phase complement

Area of Science:

• Immunology
• Hematology
• Complement System

Background:

• Group A and B erythrocytes are targets for complement-mediated lysis.
• Monoclonal IgM antibodies (anti-A and anti-B) are used to study these interactions.
• The complement system plays a crucial role in immune responses and cell lysis.

Purpose of the Study:

• To investigate the differences in lysis of erythrocytes by human complement using anti-A and anti-B IgM monoclonal antibodies.
• To determine the correlation between membrane-bound immunoglobulin concentration and competitive capacity.
• To elucidate the role of C1q and C3 binding in the differential activity of anti-A and anti-B antibodies.

Main Methods:

• Utilized a 51Cr-release assay to measure erythrocyte lysis.
• Employed flow cytometry to quantify membrane-bound immunoglobulins.
• Measured C1q and C3 binding using purified, 125I-labelled molecules.
• Conducted a cold target competition assay to assess indirect effects of antibodies.

Main Results:

• Direct hemolysis was similar for both anti-A and anti-B antibodies across various complement and antibody concentrations.
• Competitive capacity of sensitized erythrocytes correlated with membrane-bound immunoglobulin levels.
• Anti-B antibodies required a 2-4 times higher concentration than anti-A antibodies for equivalent lysis in competition assays.
• Differential competitive activity is attributed to variations in C1q and C3 binding capacities.

Conclusions:

• The study highlights distinct mechanisms of complement activation by anti-A and anti-B IgM antibodies.
• Differences in C1q and C3 binding are key factors influencing the efficacy of these antibodies in complement-mediated lysis.
• Findings provide insights into antibody interactions with the complement system and erythrocyte lysis.